AI-based drug discovery platform Peptris raises $1-M led by Speciale Invest

Bengaluru-based drug discovery startup Peptris has raised USD 1 million in its pre seed round led by Speciale Invest. The money will be used to increase the firm's efforts in the drug research and discovery space to advance AI-driven solutions. It will focus on creating new treatments for rare diseases, inflammation, and oncology. Founded by Narayanan Venkatasubramanian, Anand Budni, and Amit Mahajan, Peptris has developed an AI/ML based computational platform to accelerate the process of finding novel drugs.